PDF(Pubmed)
Abstract：
UNASSIGNED: This study explores the clinical application value of medical adhesive in endovascular embolization treatment of peripheral pseudoaneurysm.
UNASSIGNED: This was a retrospective review on 31 patients with peripheral pseudoaneurysm treated with medical adhesive endovascular embolization at the First Affiliated Hospital of Shihezi University from July 2021 to July 2023. Follow-up for 3-6 months was to observe the clinical efficacy and postoperative complications of medical adhesive embolization treatment.
UNASSIGNED: A total of 32 pseudoaneurysms were embolized in 31 patients with peripheral pseudoaneurysms. All pseudoaneurysms originated from visceral arteries. Among them, 29 pseudoaneurysms were embolized with medical adhesive alone, and three pseudoaneurysms were embolized with coil-assisted medical adhesive. After endovascular embolization with medical adhesive, all pseudoaneurysms were successfully embolized. Technical success was 100%. All patients experienced cessation of bleeding after endovascular embolization with medical adhesive, and there were no serious post-operative complications. Clinical success was 100%. During the follow-up period, two patients experienced recurrent bleeding but no pseudoaneurysm recurrence was observed.
UNASSIGNED: Endovascular medical adhesive embolization is a safe and effective method for treating pseudoaneurysm, with high hemostatic efficiency and permanent occlusion of the pseudoaneurysm after embolization, which is worthy of clinical promotion and application.
UNASSIGNED: This was a retrospective review on 31 patients with peripheral pseudoaneurysm treated with medical adhesive endovascular embolization at the First Affiliated Hospital of Shihezi University from July 2021 to July 2023. Follow-up for 3-6 months was to observe the clinical efficacy and postoperative complications of medical adhesive embolization treatment.
UNASSIGNED: A total of 32 pseudoaneurysms were embolized in 31 patients with peripheral pseudoaneurysms. All pseudoaneurysms originated from visceral arteries. Among them, 29 pseudoaneurysms were embolized with medical adhesive alone, and three pseudoaneurysms were embolized with coil-assisted medical adhesive. After endovascular embolization with medical adhesive, all pseudoaneurysms were successfully embolized. Technical success was 100%. All patients experienced cessation of bleeding after endovascular embolization with medical adhesive, and there were no serious post-operative complications. Clinical success was 100%. During the follow-up period, two patients experienced recurrent bleeding but no pseudoaneurysm recurrence was observed.
UNASSIGNED: Endovascular medical adhesive embolization is a safe and effective method for treating pseudoaneurysm, with high hemostatic efficiency and permanent occlusion of the pseudoaneurysm after embolization, which is worthy of clinical promotion and application.
摘要：
■本研究探讨医用粘合剂在周围型假性动脉瘤血管内栓塞治疗中的临床应用价值。
■这是一项对2021年7月至2023年7月在石河子大学第一附属医院接受医用粘合剂血管内栓塞治疗的31例周围假性动脉瘤患者的回顾性研究。随访3～6个月,观察医用胶粘剂栓塞治疗的临床疗效及术后并发症。
■在31例周围假性动脉瘤患者中共栓塞了32个假性动脉瘤。所有假性动脉瘤均起源于内脏动脉。其中,仅使用医用粘合剂栓塞29个假性动脉瘤，用线圈辅助医用粘合剂栓塞三个假性动脉瘤。用医用粘合剂进行血管内栓塞后，所有假性动脉瘤均成功栓塞.技术成功100%。所有患者使用医用粘合剂进行血管内栓塞后出血停止，术后无严重并发症。临床成功率为100%。在后续期间,2例患者经历了复发性出血,但未观察到假性动脉瘤复发.
■血管内药物粘连栓塞是治疗假性动脉瘤的一种安全有效的方法，具有高止血效率和栓塞后假性动脉瘤的永久闭塞，值得临床推广应用。
■这是一项对2021年7月至2023年7月在石河子大学第一附属医院接受医用粘合剂血管内栓塞治疗的31例周围假性动脉瘤患者的回顾性研究。随访3～6个月,观察医用胶粘剂栓塞治疗的临床疗效及术后并发症。
■在31例周围假性动脉瘤患者中共栓塞了32个假性动脉瘤。所有假性动脉瘤均起源于内脏动脉。其中,仅使用医用粘合剂栓塞29个假性动脉瘤，用线圈辅助医用粘合剂栓塞三个假性动脉瘤。用医用粘合剂进行血管内栓塞后，所有假性动脉瘤均成功栓塞.技术成功100%。所有患者使用医用粘合剂进行血管内栓塞后出血停止，术后无严重并发症。临床成功率为100%。在后续期间,2例患者经历了复发性出血,但未观察到假性动脉瘤复发.
■血管内药物粘连栓塞是治疗假性动脉瘤的一种安全有效的方法，具有高止血效率和栓塞后假性动脉瘤的永久闭塞，值得临床推广应用。
